Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hyman

Showing results (281-290 of 401) with videos related to

Pageof 41
Sort By:
Cancer Research|September 28, 2017
Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its InhibitionRona Yaeger, Zhan Yao, David M Hyman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Clinical and molecular characterization of patients with cancer of unknown primary in the modern eraA M Varghese, A Arora, M Capanu, et al.
Nature Chemical Biology|January 20, 2009
A small molecule that binds Hedgehog and blocks its signaling in human cellsBenjamin Z Stanton, Lee F Peng, Nicole Maloof, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockadeJoel M Hyman, Ari J Firestone, Vivi M Heine, et al.
The Journal of Molecular Diagnostics : JMD|December 22, 2018
Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical ManagementSounak Gupta, Chad M Vanderbilt, Paolo Cotzia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2018
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian CancerKatherine LaVigne, David M Hyman, Qin C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2014
The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancerJ L Meisel, D M Hyman, K Garg, et al.
Scientific Reports|September 27, 2018
ADIPOR1 is essential for vision and its RPE expression is lost in the Mfrp<sup>rd6</sup> mouseValentin M Sluch, Angela Banks, Hui Li, et al.
Cell Stem Cell|August 15, 2017
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical OutcomesCatherine C Coombs, Ahmet Zehir, Sean M Devlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver MutationsEzra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Pageof 41

Showing results (281-290 of 401) with videos related to

Sort By:
Pageof 41
Cancer Research|September 28, 2017
Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its InhibitionRona Yaeger, Zhan Yao, David M Hyman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2017
Clinical and molecular characterization of patients with cancer of unknown primary in the modern eraA M Varghese, A Arora, M Capanu, et al.
Nature Chemical Biology|January 20, 2009
A small molecule that binds Hedgehog and blocks its signaling in human cellsBenjamin Z Stanton, Lee F Peng, Nicole Maloof, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockadeJoel M Hyman, Ari J Firestone, Vivi M Heine, et al.
The Journal of Molecular Diagnostics : JMD|December 22, 2018
Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical ManagementSounak Gupta, Chad M Vanderbilt, Paolo Cotzia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2018
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian CancerKatherine LaVigne, David M Hyman, Qin C Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2014
The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancerJ L Meisel, D M Hyman, K Garg, et al.
Scientific Reports|September 27, 2018
ADIPOR1 is essential for vision and its RPE expression is lost in the Mfrp<sup>rd6</sup> mouseValentin M Sluch, Angela Banks, Hui Li, et al.
Cell Stem Cell|August 15, 2017
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical OutcomesCatherine C Coombs, Ahmet Zehir, Sean M Devlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2019
TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver MutationsEzra Y Rosen, Debra A Goldman, Jaclyn F Hechtman, et al.
Pageof 41